Aryl substituted thiazolidinones and the use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 30, 2007
Issued Date -
N/A
app pub date -
Jul 16, 2002
filing date -
Jul 16, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates aryl substituted thiazolidinones of Formula I: ##STR00001## or a pharmaceutically acceptable salt, or solvate thereof, wherein R.sub.1 and R.sub.2, are defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully